MY115721A - Benzothiophene compounds, intermediates, compositionsm, and methods - Google Patents
Benzothiophene compounds, intermediates, compositionsm, and methodsInfo
- Publication number
- MY115721A MY115721A MYPI96000722A MYPI9600722A MY115721A MY 115721 A MY115721 A MY 115721A MY PI96000722 A MYPI96000722 A MY PI96000722A MY PI9600722 A MYPI9600722 A MY PI9600722A MY 115721 A MY115721 A MY 115721A
- Authority
- MY
- Malaysia
- Prior art keywords
- alkyl
- compositionsm
- intermediates
- methods
- compounds
- Prior art date
Links
- FCEHBMOGCRZNNI-UHFFFAOYSA-N 1-benzothiophene Chemical class C1=CC=C2SC=CC2=C1 FCEHBMOGCRZNNI-UHFFFAOYSA-N 0.000 title 1
- 239000000543 intermediate Substances 0.000 title 1
- -1 1-PIPERIDINYL Chemical group 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 2
- XSXHWVKGUXMUQE-UHFFFAOYSA-N osmium dioxide Inorganic materials O=[Os]=O XSXHWVKGUXMUQE-UHFFFAOYSA-N 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D333/64—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/396,401 US5510357A (en) | 1995-02-28 | 1995-02-28 | Benzothiophene compounds as anti-estrogenic agents |
| US55276095A | 1995-11-03 | 1995-11-03 | |
| US08/552,636 US5723474A (en) | 1995-02-28 | 1995-11-03 | Benzothiophene compounds, intermediates, compositions, and methods |
| US08/552,565 US5977093A (en) | 1995-02-28 | 1995-11-03 | Benzothiophene compounds, intermediates, compositions, and methods |
| US08/554,223 US5856340A (en) | 1995-02-28 | 1995-11-03 | Method of treating estrogen dependent cancers |
| US08/552,564 US5998441A (en) | 1995-02-28 | 1995-11-03 | Benzothiophene compounds, intermediates, compositions, and methods |
| US08/552,679 US5856339A (en) | 1995-02-28 | 1995-11-03 | Benzothiophene compounds, intermediates, compositions, and methods |
| US08/552,890 US5919800A (en) | 1995-02-28 | 1995-11-03 | Benzothiophene compounds, intermediates, compositions, and methods |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY115721A true MY115721A (en) | 2003-08-30 |
Family
ID=27569747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI96000722A MY115721A (en) | 1995-02-28 | 1996-02-28 | Benzothiophene compounds, intermediates, compositionsm, and methods |
Country Status (4)
| Country | Link |
|---|---|
| KR (1) | KR100446895B1 (sr) |
| MY (1) | MY115721A (sr) |
| NZ (1) | NZ286079A (sr) |
| RS (1) | RS49886B (sr) |
-
1996
- 1996-02-27 RS YUP-118/96A patent/RS49886B/sr unknown
- 1996-02-27 KR KR1019960004749A patent/KR100446895B1/ko not_active Expired - Fee Related
- 1996-02-27 NZ NZ286079A patent/NZ286079A/en not_active IP Right Cessation
- 1996-02-28 MY MYPI96000722A patent/MY115721A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100446895B1 (ko) | 2006-04-10 |
| YU11896A (sh) | 1998-12-23 |
| KR960031454A (ko) | 1996-09-17 |
| NZ286079A (en) | 1997-12-19 |
| RS49886B (sr) | 2008-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9600743A (es) | Compuestos de naftilo, intermediarios y composiciones farmaceuticas a partir de los mismos y proceso para su preparacion. | |
| GEP20084496B (en) | Benzothiophene compound, intermediate, composition, and method | |
| YU61595A (sh) | Nova naftilna jedinjenja, njihovi intermedijeri farmaceutske kompozicije, i postupci za dobijanje tih jedinjenja | |
| AR003930A1 (es) | Procedimiento para preparar compuestos de 2-fenil-3-fenoxi o feniltio-benzotiofeno y sales farmaceuticamente aceptables, compuestos intermediarios de aplicación exclusiva en dicho procedimiento y metodo para preparar los compuestos intermediarios mencionados | |
| TW200420542A (en) | A compound having TGF β inhibition activity and a medicinal composition containing the same | |
| NZ326132A (en) | Retroviral protease inhibiting compounds | |
| TW427887B (en) | Pharmaceutical composition comprising a benzimidazole derivative for treating viral infections | |
| MX9605156A (es) | Inhibidor de angiogenesis. | |
| CA2149496A1 (en) | 11,21-bisphenyl-19-norpregnane derivatives | |
| AU7517400A (en) | N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent | |
| DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
| MX9800718A (es) | Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida. | |
| NZ308518A (en) | Antibacterial cephalosporins | |
| MX9800800A (es) | Compuestos, intermedios de naftilo y dihidronaftilo, composiciones y metodos. | |
| TW372969B (en) | Pharmaceutical composition for minimizing bone loss | |
| DE69421694D1 (en) | Interleukin-1 inhibitor | |
| CA2170479A1 (en) | Benzothiophene compounds, intermediates, compositions, and methods | |
| YU6996A (sh) | Upotreba benzotiofena za dobijanje leka | |
| PT832881E (pt) | Compostos de benzofluoreno intermediarios composicoes e metodos | |
| MY113757A (en) | Methods of inhibiting endometrial cancer | |
| GB2333293B (en) | Process for the preparation of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide used as anti cancer compounds | |
| TW349096B (en) | Benzothiophene compounds, intermediates, compositions, and methods | |
| YU11896A (sh) | Benzotiofenska jedinjenja, intermedijeri, kompozicije koje ih sadrže |